Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- priority_score
- Composite prioritisation = 0.30*biology + 0.30*reagent-gap + 0.20*druggability + 0.10*disease + 0.10*novelty. Sub-scores are assigned during LLM-assisted curation — a heuristic ranking, NOT an experimental measurement.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- 1 if in the EV-Map circulating-EV proteome (Rai 2025); 3,422 targets.
- has_known_aptamer
- 1 if aptamer evidence found in PubMed/Aptagen (1,472 targets).
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for this protein AND (aptamer OR SELEX).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
102 rows where has_cryoEM = 1, has_known_aptamer = 1 and tier = "Tier 1.5" sorted by priority_score descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 102 ✖
has_known_aptamer 1
- 1 · 102 ✖
has_cryoEM 1
- 1 · 102 ✖
has_activation_state_pdb_pair 1
- 0 102
| id | gene_symbol | protein_name | tier | priority_score ▲ | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | drug_count_approved | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P25445 | FAS | Tumor necrosis factor receptor superfamily member 6 | Tier 1.5 | 0.914 | 7 | 77.88 | 1 | 0 | 1 | 17 | 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 | 1 | autoimmune lymphoproliferative syndrome type 1 | 0.7377210386590284 | |||
| P21583 | KITLG | Kit ligand | Tier 1.5 | 0.848 | 6 | 71.88 | 1 | 0 | 1 | 2 | 36579647, 23967247 | 0 | hyperpigmentation with or without hypopigmentation, familial progressive | 0.6756727302967072 | |||
| Q00975 | CACNA1B | Voltage-dependent N-type calcium channel subunit alpha-1B | Tier 1.5 | 0.807 | 7 | 59.91 | 1 | 0 | 1 | 2 | 31118475, 25782368 | 0 | Seizure | 0.7217241968702018 | |||
| P02748 | C9 | Complement component C9 | Tier 1.5 | 0.796 | 9 | 78.75 | 1 | 0 | 1 | 10 | 41636061, 40411682, 36428893, 36290981, 35247355, 28794177, 27836219, 22678933, 19261617, 15687383 | 1 | Immunodeficiency due to a late component of complements deficiency | 0.761965409699055 | |||
| Q13085 | ACACA | Acetyl-CoA carboxylase 1 | Tier 1.5 | 0.79 | 10 | 82.81 | 1 | 0 | 1 | 1 | 41854184 | 1 | |||||
| Q92633 | LPAR1 | Lysophosphatidic acid receptor 1 | Tier 1.5 | 0.785 | 16 | 83.62 | 1 | 0 | 1 | 1 | 32065590 | 1 | Epiretinal membrane | 0.4757255248053499 | |||
| P03971 | AMH | Anti-Muellerian hormone | Tier 1.5 | 0.783 | 3 | 68.62 | 1 | 0 | 1 | 2 | 41101154, 27364573 | 0 | persistent Mullerian duct syndrome | 0.7847328444470535 | |||
| P39060 | COL18A1 | Collagen alpha-1(XVIII) chain | Tier 1.5 | 0.769 | 9 | 50.62 | 1 | 0 | 1 | 2 | 36707842, 23679916 | 1 | Knobloch syndrome 1 | 0.7867122552672962 | |||
| P43007 | SLC1A4 | Neutral amino acid transporter A | Tier 1.5 | 0.75 | 1 | 80.56 | 1 | 0 | 1 | 6 | 36219068, 31989939, 27571928, 26811678, 19046328, 16139842 | 1 | spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome | 0.8025684205131692 | |||
| P08648 | ITGA5 | Integrin alpha-5 | Tier 1.5 | 0.748 | 14 | 85.25 | 1 | 0 | 1 | 2 | 32174798, 38258032 | 1 | skin disease | 0.28465651599598124 | |||
| O60884 | DNAJA2 | DnaJ homolog subfamily A member 2 | Tier 1.5 | 0.73 | 1 | 83.38 | 1 | 0 | 1 | 2 | 41935727, 33879515 | 1 | dengue disease | 0.37068859424875583 | |||
| Q99988 | GDF15 | Growth/differentiation factor 15 | Tier 1.5 | 0.718 | 4 | 75.69 | 1 | 0 | 1 | 29 | 41924874, 41862097, 38879214, 38477735, 37982669, 36927042, 36638554, 36508319, 36333824, 35762561, 33334063, 32527800, 31988066, 29992704, 39884764, 38497478, 38296402, 37162508, 32739349, 30335547 | 1 | hyperemesis gravidarum | 0.5821658682742563 | |||
| Q00604 | NDP | Norrin | Tier 1.5 | 0.716 | 11 | 83.56 | 1 | 0 | 1 | 2 | 39057719, 11352723 | 0 | Norrie disease | 0.8566451682188412 | |||
| P46094 | XCR1 | Chemokine XC receptor 1 | Tier 1.5 | 0.715 | 1 | 84.94 | 1 | 0 | 1 | 1 | 35212764 | 0 | COVID-19 | 0.459103766220463 | |||
| P32239 | CCKBR | Gastrin/cholecystokinin type B receptor | Tier 1.5 | 0.713 | 5 | 75.75 | 1 | 0 | 1 | 2 | 33776434, 27754762 | 0 | gastroesophageal reflux disease | 0.4256110167566802 | |||
| P25106 | ACKR3 | Atypical chemokine receptor 3 | Tier 1.5 | 0.71 | 14 | 82.44 | 1 | 0 | 1 | 2 | 40401615, 28670693 | 0 | oculomotor-abducens synkinesis | 0.49893280382434735 | |||
| P07225 | PROS1 | Vitamin K-dependent protein S | Tier 1.5 | 0.7 | 3 | 82.94 | 1 | 0 | 1 | 2 | 36859809, 33674695 | 1 | thrombophilia due to protein S deficiency, autosomal dominant | 0.8240418292042652 | |||
| P21359 | NF1 | Neurofibromin | Tier 1.5 | 0.695 | 26 | 87.19 | 1 | 0 | 1 | 2 | 32980430, 22617876 | 1 | neurofibromatosis type 1 | 0.8844735398780649 | |||
| Q96RJ3 | TNFRSF13C | Tumor necrosis factor receptor superfamily member 13C | Tier 1.5 | 0.681 | 8 | 63.03 | 1 | 0 | 1 | 1 | 23470998 | 0 | immunodeficiency, common variable, 4 | 0.660711678987284 | |||
| P98155 | VLDLR | Very low-density lipoprotein receptor | Tier 1.5 | 0.66 | 27 | 75.69 | 1 | 0 | 1 | 1 | 19188685 | 1 | Dysequilibrium syndrome | 0.790164037509625 | |||
| P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | Tier 1.5 | 0.652 | 14 | 72.69 | 1 | 0 | 1 | 4 | 33334063, 32127469, 28010895, 30594071 | 1 | gastrointestinal stromal tumor | 0.8167494524079806 | |||
| P08100 | RHO | Rhodopsin | Tier 1.5 | 0.645 | 4 | 88.75 | 1 | 0 | 1 | 45 | 41963275, 41924874, 41636061, 40808302, 40642289, 40330320, 40045571, 39863313, 39788632, 38070612, 37191882, 36705086, 36696850, 36095194, 36049339, 35622174, 34709779, 34471566, 32696702, 32479610, 32319623, 32119944, 31737572, 31588238, 31535128, 29570714, 29281176, 28648779, 27893356, 25645980, 23757206, 23701883, 25033804, 22689339, 22302221, 22121695, 19766091, 19389625, 16419035, 12123800, 8743323, 7678562, 19188685, 18230760 | 0 | retinitis pigmentosa | 0.8481942240861982 | |||
| P07237 | P4HB | Protein disulfide-isomerase | Tier 1.5 | 0.644 | 14 | 88.5 | 1 | 0 | 1 | 2 | 31625090, 28952381 | 1 | Cole-Carpenter syndrome | 0.7447295842045853 | |||
| P15391 | CD19 | B-lymphocyte antigen CD19 | Tier 1.5 | 0.642 | 4 | 62.22 | 1 | 0 | 1 | 13 | 41079126, 40652441, 38661725, 38148412, 36095289, 35829681, 34680368, 34364920, 32401486, 31912987, 29928472, 21127492 | 0 | immunodeficiency, common variable, 3 | 0.6821072538733047 | |||
| Q8NEV9 | IL27 | Interleukin-27 subunit alpha | Tier 1.5 | 0.641 | 4 | 75.62 | 1 | 0 | 1 | 2 | 35859339, 32784904 | 0 | Crohn's disease | 0.40963715551754365 | |||
| P45844 | ABCG1 | ATP-binding cassette sub-family G member 1 | Tier 1.5 | 0.639 | 5 | 81.12 | 1 | 0 | 1 | 1 | 41854184 | 0 | neurodegenerative disease | 0.3915225348167794 | |||
| P51654 | GPC3 | Glypican-3 | Tier 1.5 | 0.636 | 4 | 75.06 | 1 | 0 | 1 | 65 | 42083729, 41790019, 41653459, 41045695, 40825648, 40722645, 39998646, 39874791, 39608318, 39427046, 38910291, 38787447, 38621313, 38368644, 37665421, 36903516, 36457288, 36317566, 36072763, 35788872, 35699181, 35477501, 35051745, 34974867, 34306031, 33254049, 33080969, 32356075, 30347351, 30122918, 29675356, 29605994, 29277631, 27601357, 28263753 | 0 | Simpson-Golabi-Behmel syndrome type 1 | 0.762708583613362 | |||
| P31785 | IL2RG | Cytokine receptor common subunit gamma | Tier 1.5 | 0.635 | 14 | 75.5 | 1 | 0 | 1 | 2 | 30800133, 33869115 | 0 | gamma chain deficiency | 0.8469997000418428 | |||
| O75976 | CPD | Carboxypeptidase D | Tier 1.5 | 0.625 | 3 | 82.5 | 1 | 0 | 1 | 1 | 36457699 | 1 | neurodegenerative disease | 0.34777406871587735 | |||
| O95342 | ABCB11 | Bile salt export pump | Tier 1.5 | 0.624 | 8 | 83.12 | 1 | 0 | 1 | 1 | 36313979 | 0 | progressive familial intrahepatic cholestasis type 2 | 0.8372060401943777 | |||
| P49238 | CX3CR1 | CX3C chemokine receptor 1 | Tier 1.5 | 0.62 | 2 | 80.5 | 1 | 0 | 1 | 2 | 28727998 | 0 | age-related macular degeneration | 0.4006854573775187 | |||
| Q06141 | REG3A | Regenerating islet-derived protein 3-alpha | Tier 1.5 | 0.62 | 4 | 89.0 | 1 | 0 | 1 | 2 | 39695715, 24771595 | 0 | alcohol drinking | 0.29724052454892086 | |||
| Q9ULC3 | RAB23 | Ras-related protein Rab-23 | Tier 1.5 | 0.619 | 6 | 79.56 | 1 | 0 | 1 | 1 | 23618401 | 1 | RAB23-related Carpenter syndrome | 0.7879955689930709 | |||
| Q07325 | CXCL9 | C-X-C motif chemokine 9 | Tier 1.5 | 0.617 | 1 | 87.44 | 1 | 0 | 1 | 7 | 42046114, 37395276, 35204399, 35018777, 33742062, 27959341, 27819142 | 0 | neoplasm | 0.1199067650750674 | |||
| P01876 | IGHA1 | Immunoglobulin heavy constant alpha 1 | Tier 1.5 | 0.612 | 14 | 81.88 | 1 | 0 | 1 | 2 | 37325361 | 1 | IGA glomerulonephritis | 0.12053726815801102 | |||
| O43866 | CD5L | CD5 antigen-like | Tier 1.5 | 0.61 | 4 | 85.88 | 1 | 0 | 1 | 3 | 40215752, 37100807 | 1 | functional neutrophil defect | 0.3529395470693119 | |||
| P41146 | OPRL1 | Nociceptin receptor | Tier 1.5 | 0.61 | 4 | 82.31 | 1 | 0 | 1 | 1 | 14970396 | 0 | neurodegenerative disease | 0.4039002828932129 | |||
| P23368 | ME2 | NAD-dependent malic enzyme, mitochondrial | Tier 1.5 | 0.61 | 18 | 94.38 | 1 | 0 | 1 | 2 | 39602246, 29779113 | 1 | diabetes mellitus | 0.277416610655893 | |||
| P15529 | CD46 | Membrane cofactor protein | Tier 1.5 | 0.608 | 7 | 82.12 | 1 | 0 | 1 | 9 | 35114109, 34248841, 31761039, 31077760, 27734375, 19915929, 17046833, 11084032 | 1 | atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | 0.7798469882597787 | |||
| P55157 | MTTP | Microsomal triglyceride transfer protein large subunit | Tier 1.5 | 0.608 | 2 | 86.56 | 1 | 0 | 1 | 1 | 23770039 | 1 | abetalipoproteinemia | 0.8281089516017405 | |||
| P04201 | MAS1 | Proto-oncogene Mas | Tier 1.5 | 0.605 | 3 | 83.5 | 1 | 0 | 1 | 10 | 40518278, 34016094, 30415442, 27936442, 23618401 | 0 | Abnormality of the skeletal system | 0.40450059258174326 | |||
| P10646 | TFPI | Tissue factor pathway inhibitor | Tier 1.5 | 0.605 | 9 | 73.62 | 1 | 0 | 1 | 28 | 32366845, 32224381, 30994257, 30302740, 27563744, 27196067, 24263002, 23528042, 22951415, 22658294, 22632032, 22239993, 21696535, 21389323, 8578509, 25521966, 24319161 | 1 | hemophilia A | 0.5591056672248635 | |||
| P41231 | P2RY2 | P2Y purinoceptor 2 | Tier 1.5 | 0.605 | 3 | 78.88 | 1 | 0 | 1 | 1 | 33911033 | 0 | nontoxic goiter | 0.43556889579550895 | |||
| Q8NER1 | TRPV1 | Transient receptor potential cation channel subfamily V member 1 | Tier 1.5 | 0.6 | 8 | 71.94 | 1 | 0 | 1 | 2 | 40855286, 28604222 | 0 | migraine disorder | 0.6269329225883602 | |||
| P0DSE1 | TRA | M1-specific T cell receptor alpha chain | Tier 1.5 | 0.6 | 3 | 88.81 | 1 | 0 | 1 | 7 | 41693575, 41636061, 39837202, 37015819, 28860472, 25844955, 19457263 | 0 | |||||
| P02786 | TFRC | Transferrin receptor protein 1 | Tier 1.5 | 0.587 | 22 | 86.69 | 1 | 0 | 1 | 3 | 39831311, 29046922, 32527800 | 1 | TFRC-related combined immunodeficiency | 0.623449899069336 | |||
| P31948 | STIP1 | Stress-induced-phosphoprotein 1 | Tier 1.5 | 0.585 | 8 | 89.75 | 1 | 0 | 1 | 7 | 41406518, 38012811, 34831332, 32614006, 27681499, 24654750, 24013070 | 1 | neurodegenerative disease | 0.4967711525222825 | |||
| Q15813 | TBCE | Tubulin-specific chaperone E | Tier 1.5 | 0.582 | 6 | 89.19 | 1 | 0 | 1 | 1 | 34448574 | 1 | hypoparathyroidism-retardation-dysmorphism syndrome | 0.7744447925917005 | |||
| P55259 | GP2 | Pancreatic secretory granule membrane major glycoprotein GP2 | Tier 1.5 | 0.577 | 4 | 78.62 | 1 | 0 | 1 | 3 | 36902059, 25483705, 24334484 | 0 | type 2 diabetes mellitus | 0.5235291484788168 | |||
| P08887 | IL6R | Interleukin-6 receptor subunit alpha | Tier 1.5 | 0.575 | 10 | 77.88 | 1 | 0 | 1 | 18 | 40853309, 38152968, 37034659, 36579647, 35890412, 33590853, 33340765, 32515246, 29211023, 28929152, 26552813, 26383776, 24481022, 24440854, 23235494, 22503683, 22258147, 22094809 | 0 | rheumatoid arthritis | 0.7269057706798291 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS SELECT f.id, n.gene_symbol, n.protein_name, tg.tier, f.priority_score, f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM, f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive, f.drug_count_approved, f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids, f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score FROM v_target_full f LEFT JOIN target_names n ON n.target_id=f.id LEFT JOIN targets tg ON tg.id=f.id LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id;